中国医药导报2024,Vol.21Issue(19) :35-39.DOI:10.20047/j.issn1673-7210.2024.19.07

孕激素抵抗在子宫内膜异位症发病机制中的研究进展

Research progress on progesterone resistance in the pathogenesis of endometriosis

毛明玉 李全喜 苗聪秀 任雪英
中国医药导报2024,Vol.21Issue(19) :35-39.DOI:10.20047/j.issn1673-7210.2024.19.07

孕激素抵抗在子宫内膜异位症发病机制中的研究进展

Research progress on progesterone resistance in the pathogenesis of endometriosis

毛明玉 1李全喜 2苗聪秀 2任雪英3
扫码查看

作者信息

  • 1. 长治医学院第二临床学院,山西长治 046013
  • 2. 长治医学院附属和平医院生殖遗传科,山西长治 046099
  • 3. 长治医学院附属和济医院妇科,山西长治 046011
  • 折叠

摘要

子宫内膜异位症(EMT)中异位内膜的生长依赖雌激素的持续刺激,孕激素因具有抑制雌激素对子宫内膜的增殖和抗凋亡的作用,常被用于控制EMT症状和延缓复发.临床治疗中,部分EMT患者子宫内膜对孕激素类制剂治疗表现低反应,甚至无反应,该现象为孕激素抵抗.孕激素受体(PR)表达缺陷、PR活性降低和PR信号传导异常干扰孕激素信号传导,导致孕激素抵抗.本文总结近年来EMT中由PR异常导致孕激素抵抗相关的分子机制,期望通过逆转孕激素抵抗现象,从而研发新的针对EMT及其不孕症的治疗方案.

Abstract

The growth of ectopic endometrium in endometriosis(EMT)depends on the continuous stimulation of estrogen.Progesterone is often used to control EMT symptoms and delay recurrence due to its inhibitory effect on estrogen proliferation and anti-apoptosis of the endometrium.In clinical treatment,some EMT patients exhibit low or even no response to progesterone preparations in the endometrium,which is a phenomenon of progesterone resistance.Defective expression of progesterone receptor(PR),decreased PR activity,and abnormal PR signaling interfere with progesterone signaling,leading to progesterone resistance.This article summarizes molecular mechanisms related to progesterone resistance caused by PR abnormalities in EMT in recent years,aiming to reverse the phenomenon of progesterone resistance and develop new treatment plans for EMT and its infertility.

关键词

子宫内膜异位症/孕激素受体/孕激素抵抗

Key words

Endometriosis/Progesterone receptor/Progesterone resistance

引用本文复制引用

基金项目

国家自然科学基金面上项目(31971073)

出版年

2024
中国医药导报
中国医学科学院

中国医药导报

CSTPCD
影响因子:1.759
ISSN:1673-7210
段落导航相关论文